Matucci Andrea

7PUBLICATIONS
6CO-AUTHORS
AllergyMedical infection agents (incl. prions)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 25, 2022
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control.

Emanuele Vivarelli, Andrea Matucci, Paola Parronchi

|Feb 03, 2022
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.

Andrea Matucci, Emanuele Vivarelli, Susanna Bormioli

|Jan 28, 2021
Self-administration of omalizumab: why not? A literature review and expert opinion.

Francesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci

|Dec 07, 2020
The emerging role of type 2 inflammation in asthma.

Matucci Andrea, Bormioli Susanna, Nencini Francesca

|Jul 09, 2020
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.

Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli

|May 21, 2020
Immunogenicity-unwanted immune responses to biological drugs - can we predict them?

Andrea Matucci, Francesca Nencini, Emanuele Vivarelli

Pageof 2